RBC Life Sciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: November 15, 2014
Pages: 50
Price:
US$ 499.00
RBC Life Sciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default), Hard Copy Mail Delivery (+US$ 190.00)
ID: RBF78E2AF65BEN
Leaflet:

Download PDF Leaflet

RBC Life Sciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
RBC Life Sciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between RBC Life Sciences Inc. and its competitors. This provides our Clients with a clear understanding of RBC Life Sciences Inc. position in the Consumer Products Industry.

  • The report contains detailed information about RBC Life Sciences Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for RBC Life Sciences Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The RBC Life Sciences Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes RBC Life Sciences Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of RBC Life Sciences Inc. business.

About RBC Life Sciences Inc.

RBC Life Sciences, Inc. engages in the marketing and distribution of nutritional supplements and personal care products in the U.S. and Canada. The company’s product line is marketed under the ‘RBC Life’ brand name and may be categorized as: wellness products, fitness products, and skin care products. The product line includes herbal formulas, vitamins, minerals, antioxidants and skin, hair and body care products.

Products

The Nutritional Products segment markets nutritional supplements and personal care products under the RBC Life brand name. The Medical Products segment markets wound care products under the MPM Medical brand name.

Nutritional Products segment

The company markets a line of approximately 75 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. These products may be categorized as: wellness products, fitness products, and skin care products. Featured products include Microhydrin and Microhydrin Plus –broad-spectrum antioxidants; NeuroBright – introduced in August 2009, this product supports healthy brain function and enhances energy and acuity; Organic spirulina – sold in powder, tablet, capsule, and in combination with other ingredients, bar forms, a nutritious algae that provides a range of vital nutrients and a percentage of digested protein than meat; OliViva – made from freshly harvested olive leaves, an antioxidant beverage that supports the immune system, increases energy and supports the cardiovascular system; ColoVada Plus – a fourteen-day colon cleansing program; HydraCel – a product that improves the quality of drinking water by reducing surface tension for increased hydration and making water more alkaline; 24 Seven – a daily multivitamin/mineral supplement; Immune 360 – a product to nourish and support the function of the immune system; Digestion Formula – a combination of digestive enzymes to supplement the decline of enzymes that naturally occurs with aging; and Cellution 7 – a science-based skin care product collection that incorporates ingredients.

The company’s primary products are antioxidant products marketed under the trade names Microhydrin and Microhydrin Plus. Its finished products are produced according to its specifications and/or formulas by manufacturers and suppliers that the company does not control.

Medical Products segment

The company’s Medical Products are produced according to its specifications and/or formulas by manufacturers and suppliers. The company markets a line of approximately 28 wound care products. Certain wound care products are for the treatment and healing of wounds such as pressure ulcers, leg ulcers, cuts, burns and abrasions. These products include cleansers, dressings, hydrogels, calcium alginates, moisture barriers, antimicrobials and a hydrogel wound dressing with Lidocaine. The company distributes wound care products primarily in the U.S. to hospitals, nursing homes, clinics, pharmacies and home health care agencies.

Suppliers

The company contracts with third-party manufacturers and suppliers, such as Progressive Laboratories, Inc., Brady Precision Converting, LLC, Merical Vita-Pak, Inc. and Pacific Nutritional, Inc.

History

The company was founded in 1988. It was formerly known as Royal BodyCare, Inc. and changed its name to RBC Life Sciences, Inc. in 2006.


RESEARCH METHODOLOGY

DISCLAIMER

1. RBC LIFE SCIENCES INC. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. RBC LIFE SCIENCES INC. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. RBC LIFE SCIENCES INC. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. RBC LIFE SCIENCES INC. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. RBC LIFE SCIENCES INC. COMPETITORS AND INDUSTRY ANALYSIS

5.1. RBC Life Sciences Inc. Direct Competitors
5.2. Comparison of RBC Life Sciences Inc. and Direct Competitors Financial Ratios
5.3. Comparison of RBC Life Sciences Inc. and Direct Competitors Stock Charts
5.4. RBC Life Sciences Inc. Industry Analysis
  5.4.1. Consumer Products Industry Snapshot
  5.4.2. RBC Life Sciences Inc. Industry Position Analysis

6. RBC LIFE SCIENCES INC. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. RBC LIFE SCIENCES INC. EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. RBC LIFE SCIENCES INC. ENHANCED SWOT ANALYSIS2

9. RBC LIFE SCIENCES INC. PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. RBC LIFE SCIENCES INC. PORTER FIVE FORCES ANALYSIS2

11. RBC LIFE SCIENCES INC. VRIO ANALYSIS2


APPENDIX 1: RATIO DEFINITIONS


LIST OF TABLES

RBC Life Sciences Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
RBC Life Sciences Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
RBC Life Sciences Inc. Major Shareholders
RBC Life Sciences Inc. History
RBC Life Sciences Inc. Products
Revenues by Product
Revenues by Region
RBC Life Sciences Inc. Offices and Representations
RBC Life Sciences Inc. SWOT Analysis
Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
RBC Life Sciences Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
RBC Life Sciences Inc. Capital Market Snapshot
RBC Life Sciences Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Consumer Products Industry Statistics
RBC Life Sciences Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
RBC Life Sciences Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1
Enhanced SWOT Analysis2
Porter Five Forces Analysis2

LIST OF FIGURES

RBC Life Sciences Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
RBC Life Sciences Inc. 1-year Stock Charts
RBC Life Sciences Inc. 5-year Stock Charts
RBC Life Sciences Inc. vs. Main Indexes 1-year Stock Chart
RBC Life Sciences Inc. vs. Direct Competitors 1-year Stock Charts
RBC Life Sciences Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price. Please note that preparation of additional types of analyses requires extra time.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a Project Plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as STEP, PESTLE, STEEP, STEEPLE, STEEPLED, etc.) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislations will exert influence on the style the business is carried out?

Porter Five Forces Analysis

The extended Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions followed by sixth question added to the original concept:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?
  6. Is there any complementary products, government decisions or public perception that can impact business?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to Imitate?
  • Organized Properly?

Ask Your Question

RBC Life Sciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: